GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dianthus Therapeutics Inc (NAS:DNTH) » Definitions » Dividend Yield %

Dianthus Therapeutics (Dianthus Therapeutics) Dividend Yield % : 0.00% (As of Jun. 05, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Dianthus Therapeutics Dividend Yield %?

As of today (2024-06-05), the Trailing Annual Dividend Yield of Dianthus Therapeutics is 0.00%.

The historical rank and industry rank for Dianthus Therapeutics's Dividend Yield % or its related term are showing as below:

DNTH's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.58
* Ranked among companies with meaningful Dividend Yield % only.

Dianthus Therapeutics's Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00.

As of today (2024-06-05), the Forward Dividend Yield % of Dianthus Therapeutics is 0.00%.

Dianthus Therapeutics's Dividends per Share for the three months ended in Mar. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Dianthus Therapeutics Dividend Yield % Historical Data

The historical data trend for Dianthus Therapeutics's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dianthus Therapeutics Dividend Yield % Chart

Dianthus Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Dividend Yield %
- - -

Dianthus Therapeutics Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Dividend Yield % Get a 7-Day Free Trial - - - - -

Competitive Comparison of Dianthus Therapeutics's Dividend Yield %

For the Biotechnology subindustry, Dianthus Therapeutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dianthus Therapeutics's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dianthus Therapeutics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Dianthus Therapeutics's Dividend Yield % falls into.



Dianthus Therapeutics Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Dianthus Therapeutics  (NAS:DNTH) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Dianthus Therapeutics Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Dianthus Therapeutics's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dianthus Therapeutics (Dianthus Therapeutics) Business Description

Traded in Other Exchanges
Address
7 Times Square, 43rd Floor, New York, NY, USA, 10036
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, best-in-class monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is comprised of an experienced team of biotech and pharma executives who are leading the next generation of antibody complement therapeutics, aiming to deliver transformative medicines for people living with severe autoimmune diseases.

Dianthus Therapeutics (Dianthus Therapeutics) Headlines